Elevation of serum igf-1 rather than sex steroids precedes prolif erative diabetic retinopathy in mauriac’s syndrome

Hormone Research in Paediatrics

Volumn 48, Issue 3, 1997, Pages 131-134

  Chantelau, E ^a   Seppel, T ^a   Althaus, C ^a   Schonau E ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Complications; Diabetes mellitus; Glycosylated hemoglobin; Metabolic control; Retinopathy

Indexed keywords

FOLLITROPIN; GLYCOSYLATED HEMOGLOBIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; TRIPTORELIN;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LASER COAGULATION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MAURIAC SYNDROME; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA DEGENERATION; RISK FACTOR; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

ADULT; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC RETINOPATHY; GONADOTROPIN-RELEASING HORMONE; GROWTH DISORDERS; HEPATOMEGALY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; SYNDROME;

EID: 0030864489     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185502     Document Type: Article

References (23)

1. Danenian D, Drash AL, Lobes LA, Becker DJ, Baker LM, Travis LB: Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome), Diabetes Care 1981:4: 360-365.
2. Mauras N, Merimee T, Rogol AD: Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded child: Evidence for defective target organ responsiveness in the Mauriac syndrome, Metabolism 1991:40:1106-1111.
3. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA: Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus, J Clin Endocrinol Metab 1995; 80:1312-1317.
4. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R, D'Alessio D: Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes, J Clin Endocrinol Metab 1995: 80:2139-2143.
5. Dünger DB: Insulin and insulin-like growth factors in diabetes mellitus, Arch Dis Child 1995;72:469-471.
6. Aldington SJ, Kohner EM, Mcurcr S, Klein R, Sjolie AK, for the EURODIAB-IDDM Complications Study Group: Methodology for retinal photography and assessment of diabetic retinopathy: The F, UROD1AB IDDM Complications Study, Diabctologia 1995:38:437-444.
7. Chantelau E: Rapidly progressing diabetic retinopathy upon improved metabolic control (letter), J Diabetes Complications 1993;7:63-64.
8. Williamson JR, Tilton RG, Chang K, Kilo C: The role of sex hormones in the pathogenesis of diabetic complications; in Laron Z, Karp M (eds): Prognosis of Diabetes in Children, Pc-diatr Adolesc Endocrinol, Basel, Karger, 1989; 18:8-14.
9. Chantelau E, Eggert H, Seppel T, Schönau E, Althaus C: Elevation of serum 1GF-1 precedes proliferative diabetic retinopathy in Mauriac’s syndrome (letter), Br J Ophthalmol 1997:81: 169-170.
10. Moskalcts E, Galstyan G, Starostina E, Antsife-rov M, Chantelau E: Association of blindness to intensification of glvccmic control in insulin-dependent diabetes mellitus, J Diabetes Complications 1994:8:45-50.
11. Henricsson M, Janzon L, Groop L: Progression of retinopathy after change of treatment from oral antihypcrglycemic agents to insulin in patients with N1DDM, Diabetes Care 1995:18: 1571-1576.
12. Hyer SL, Sharp PS, Sleightholm M, Burrin JM, Kohner EM: Progression of diabetic retinopathy and changes in scrum insulin-like growth factor I (IGF-I) during continuous subcutaneous insulin infusion (CSII), Horm Metabol Res 1989:21:18-22.
13. Garg SK, Chase P, Marshall G, Hoops SL, Holmes DL, Jackson WE:Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus, JAMA 1994;271:1099-1102.
14. Bell DSH: Lack of long-term diabetic complications in spite of poor glycemic control in twins with pure gonadal dvsgenesis, Diabetes Care 1995;18:1286-1287.
15. Halfner SM, Klein R, Moss S, Klein BEK: Sex hormones and the incidence of severe retinopathy in male subjects with type-1 diabetes, Ophthalmology 1993:100:1782-1786.
16. Merimee TJ, Zapf J, Froesch ER: Insulin-like growth factors: Studies in diabetics with and without retinopathy, N Engl J Med 1983:309: 527-530.
17. Merimee T: Diabetic retinopathy, A synthesis of perspectives, N Engl J Med 1990:322:978- 983.
18. Gucvara-Aguirre J, Vasconcz O, Martinez V, Martinez AL, Rosenbloom AL, Diamond FB, Gargosky SE, Nonoshita L„ Rosenfcld RG: A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency, J Clin Endocrinol Metab 1995;80:1393-1398.
19. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Frcybcrgcr H, Klein M, Losche C, Rollmann R, Schatz H: Vitreous levels of insulin-like growth factors I and II and the insulin-like growth factor binding proteins 2 and 3 increase in neovas-cular eye disease, J Clin Invest
20. Wang Q, Dills DG, Klein R, Klein BEK, Moss S: Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy? Diabetes 1995:44:161-164.
21. Chew EY, Mills JL, Metzger BE, et al: Metabolic control and progression of retinopathy, The Diabetes in Early Pregnancy Study, Diabetes Care 1995;18:631-637.
22. Kirkcgaard C, Norgaard K, Snorgaard O, Bek T, Larsen M, Lund-Anderscn H: Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in type-1 (insulin-dependent) diabetes mellilus, Acta Endocrinol (Copenh) 1990; 122: 766-772.
23. Sharp PS, Fallon TJ, Brazier OJ, Sandler L, Joplin GF, Kohner EM: Long-term follow-up of patients who underwent yttrium-90 pituitary implantation or treatment of proliferative diabetic retinopathy, Diabctologia 1987:30:199- 207